Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · IEX Real-Time Price · USD
0.380
+0.020 (5.56%)
At close: May 1, 2024, 4:00 PM
0.371
-0.009 (-2.37%)
Pre-market: May 2, 2024, 8:25 AM EDT
Senti Biosciences Revenue
In the year 2023, Senti Biosciences had annual revenue of $2.56M, a decrease of -40.25%.
Revenue (ttm)
$2.56M
Revenue Growth
-40.25%
P/S Ratio
6.79
Revenue / Employee
$53,354
Employees
48
Market Cap
17.39M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.56M | -1.73M | -40.25% |
Dec 31, 2022 | 4.29M | 1.53M | 55.23% |
Dec 31, 2021 | 2.76M | 2.20M | 387.81% |
Dec 31, 2020 | 566.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSNTI News
- 2 days ago - Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML) - GlobeNewsWire
- 5 weeks ago - Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights - GlobeNewsWire
- 4 months ago - Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program - GlobeNewsWire
- 4 months ago - Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia - GlobeNewsWire
- 6 months ago - Senti Bio Announces Third Quarter 2023 Results and Pipeline Updates - GlobeNewsWire
- 6 months ago - Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in China - GlobeNewsWire
- 6 months ago - Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer Annual Meeting - GlobeNewsWire
- 7 months ago - Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer 2023 Meeting - GlobeNewsWire